Skip to main content
. 2023 Jul 3;13(7):1502. doi: 10.3390/life13071502

Figure 2.

Figure 2

Summary of the recently reported data from the trials NRG-GY018 and RUBY on endometrial cancer immunotherapy presented at the 2023 Society of Gynecologic Oncology (SGO) Annual Meeting (Immuno—immunotherapy, CHT—chemotherapy, dMMR—deficient mismatch repair, pMMR—proficient mismatch repair).